Abiraterone Acetate
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB05812 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | migraine disorder | KG + DL |
| 2 | migraine with or without aura, susceptibility to | KG + DL |
| 3 | migraine with brainstem aura | KG + DL |
| 4 | leprosy | KG + DL |
| 5 | pulmonary hypertension | KG + DL |
| 6 | nephrogenic syndrome of inappropriate antidiuresis | KG + DL |
| 7 | rheumatoid arthritis | KG + DL |
| 8 | kyphoscoliotic heart disease | KG + DL |
| 9 | atrophoderma vermiculata | KG + DL |
| 10 | ulerythema ophryogenesis | KG + DL |
| 11 | brachydactyly-syndactyly syndrome | KG + DL |
| 12 | colobomatous microphthalmia-rhizomelic dysplasia syndrome | KG + DL |
| 13 | hyperthyroidism | KG + DL |
| 14 | resistance to thyroid hormone due to a mutation in thyroid hormone receptor beta | KG + DL |
| 15 | allergic asthma | KG + DL |
| 16 | pulmonary hypertension, primary, autosomal recessive | KG + DL |
| 17 | headache disorder | KG + DL |
| 18 | trigeminal autonomic cephalalgia | KG + DL |
| 19 | genetic multiple congenital anomalies/dysmorphic syndrome without intellectual disability | KG + DL |
| 20 | homozygous familial hypercholesterolemia | KG + DL |
| 21 | intrinsic asthma | KG + DL |
| 22 | intracranial arteriosclerosis | KG + DL |
| 23 | Smouldering systemic mastocytosis | KG + DL |
| 24 | systemic mastocytosis | KG + DL |
| 25 | Jeune syndrome situs inversus | KG + DL |
| 26 | Pierre Robin syndrome associated with a chromosomal anomaly | KG + DL |
| 27 | multiple endocrine neoplasia | KG + DL |
| 28 | Laubry-Pezzi syndrome | KG + DL |
| 29 | persistent Mullerian duct syndrome | KG + DL |
| 30 | intermittent vascular claudication | KG + DL |
| 31 | interventricular septum aneurysm | KG + DL |
| 32 | orofacial clefting syndrome | KG + DL |
| 33 | heart disease | KG + DL |
| 34 | partial deletion of the long arm of chromosome 7 | KG + DL |
| 35 | cor pulmonale | KG + DL |
| 36 | genetic syndromic Pierre Robin syndrome | KG + DL |
| 37 | disorder of fucoglycosan synthesis | KG + DL |
| 38 | partial deletion of the long arm of chromosome 22 | KG + DL |
| 39 | Prinzmetal angina | KG + DL |
| 40 | pulmonary valve disease | KG + DL |
| 41 | coronary artery disease | KG + DL |
| 42 | sciatic neuropathy | KG + DL |
| 43 | peripheral vascular disease | KG + DL |
| 44 | lymphoadenopathic mastocytosis with eosinophilia | KG + DL |
| 45 | mitral valve disease | KG + DL |
| 46 | keratosis pilaris | KG + DL |
| 47 | obsolete patella aplasia, coxa vara, and tarsal synostosis | KG + DL |
| 48 | idiopathic pulmonary arterial hypertension | KG + DL |
| 49 | Monckeberg arteriosclerosis | KG + DL |
| 50 | pulmonary hypertension, primary | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.